JP2010520213A - 高ナトリウム食の患者における高血圧の処置のためのレニン阻害剤 - Google Patents

高ナトリウム食の患者における高血圧の処置のためのレニン阻害剤 Download PDF

Info

Publication number
JP2010520213A
JP2010520213A JP2009551834A JP2009551834A JP2010520213A JP 2010520213 A JP2010520213 A JP 2010520213A JP 2009551834 A JP2009551834 A JP 2009551834A JP 2009551834 A JP2009551834 A JP 2009551834A JP 2010520213 A JP2010520213 A JP 2010520213A
Authority
JP
Japan
Prior art keywords
blood pressure
patient
visit
patients
diet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009551834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520213A5 (cg-RX-API-DMAC10.html
Inventor
アラン・エヌ・チャーニー
Original Assignee
ノバルティス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アーゲー filed Critical ノバルティス アーゲー
Publication of JP2010520213A publication Critical patent/JP2010520213A/ja
Publication of JP2010520213A5 publication Critical patent/JP2010520213A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2009551834A 2007-03-01 2008-02-28 高ナトリウム食の患者における高血圧の処置のためのレニン阻害剤 Withdrawn JP2010520213A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89238907P 2007-03-01 2007-03-01
PCT/US2008/055207 WO2008106569A1 (en) 2007-03-01 2008-02-28 Renin inhibitors for the treatment of hypertension in patients with high sodium diet

Publications (2)

Publication Number Publication Date
JP2010520213A true JP2010520213A (ja) 2010-06-10
JP2010520213A5 JP2010520213A5 (cg-RX-API-DMAC10.html) 2011-04-14

Family

ID=39509896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551834A Withdrawn JP2010520213A (ja) 2007-03-01 2008-02-28 高ナトリウム食の患者における高血圧の処置のためのレニン阻害剤

Country Status (3)

Country Link
US (1) US20100120921A1 (cg-RX-API-DMAC10.html)
JP (1) JP2010520213A (cg-RX-API-DMAC10.html)
WO (1) WO2008106569A1 (cg-RX-API-DMAC10.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor

Also Published As

Publication number Publication date
WO2008106569A1 (en) 2008-09-04
US20100120921A1 (en) 2010-05-13

Similar Documents

Publication Publication Date Title
JP5612473B2 (ja) 難聴を処置又は予防するための1−アミノ−アルキルシクロヘキサン誘導体
TW200401631A (en) Pharmaceutical composition for treating diabetes or a disease or condition associated with diabetes
EA018082B1 (ru) Препаративная форма для лечения гиперактивности при дефиците внимания, фармацевтическая композиция на ее основе и способ лечения гиперактивности при дефиците внимания
US20180311217A1 (en) Methods of treatment and compositions with xanthine oxidase inhibitors
Modi et al. Effect of food on the pharmacokinetics of osmotic controlled‐release methylphenidate HCl in healthy subjects
JP2009527477A (ja) 低紅潮ナイアシン製剤
EP3013327B1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
KR20050119106A (ko) 주의부족 과활성장애(adhd) 치료를 위한 에난티오머성암페타민 조성물
JP2016074728A (ja) 脱髄性および他の神経系疾患を患っている患者における神経認知的および/または神経精神医学的障害を改善するための4−アミノピリジンの使用
JP2022028814A (ja) エフロルニチンとスリンダクの固定用量複合製剤
JPH115738A (ja) 脳虚血に伴う神経脱落症状の予防剤および超急性期治療剤
EP4243782B1 (en) Tablet for use in treating huntington's disease and method of making the same
US20240100011A1 (en) Pediatric formulations of ferric citrate
JP2009532494A (ja) 高血圧処置のためのレニン阻害剤
KR20250165616A (ko) 고함량 단일 투여 단위 제형 및 이의 사용 방법
US20100120921A1 (en) Renin inhibitors for treatment of hypertension in patients with high sodium diet
US20260137642A1 (en) Methods of treating patients having type 1 diabetes with eflornithine
JP2023533903A (ja) Fgfr4阻害剤の経口製剤によるがんの治療方法
US20250295648A1 (en) Method for treating l-dopa-induced dyskinesia, parkinson's disease, or parkinson's disease motor disability using befiradol
JP2020536846A (ja) Fgfr選択的チロシンキナーゼ阻害剤を含む医薬組成物
WO2024231312A2 (en) Combination therapy
WO2023178250A1 (en) Treatment of tuberous sclerosis with mirdametinib
WO2026067357A1 (zh) 托吡司特药物组合物、制备方法及应用
CN116635016A (zh) 治疗亨廷顿氏病的片剂及其制备方法
EA048709B1 (ru) Таблетка для применения в лечении болезни хантингтона и способ ее приготовления

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110224

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20120319